The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
FGF21 Acts Centrally to Induce Sympathetic Nerve Activity, Energy Expenditure, and Weight Loss
Open accessAbstract
The mechanism by which pharmacologic administration of the hormone FGF21 increases energy expenditure to cause weight loss in obese animals is unknown. Here we report that FGF21 acts centrally to exert its effects on energy expenditure and body weight in obese mice. Using tissue-specific knockout mice, we show that βKlotho, the obligate coreceptor for FGF21, is required in the nervous system for these effects. FGF21 stimulates sympathetic nerve activity to brown adipose tissue through a mechanism that depends on the neuropeptide corticotropin-releasing factor. Our findings provide an unexpected mechanistic explanation for the strong pharmacologic effects of FGF21 on energy expenditure and weight loss in obese animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Weight loss likely occurs [163,165] at the expense of VAT, as evidenced by a 15% mean decrease in abdominal fat content, measured by DEXA, in obese monkeys [165].”
From The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review (2020) · cites this paper as [163]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“FGF21 further augments BAT function indirectly, by increasing SNS output [163,165] (7)”
In the citing paper
“These effects of extended FGF21 signalling in promoting weight loss through increased energy expenditure are mediated through direct actions on the central nervous system67,80–84, not adipose tissues65,67,85”
From Metabolic messengers: FGF21 (2021) · cites this paper as [80]
In the citing paper
“Instead, FGF21 signals directly to the CNS (Fig. 3a), at least in rodents, and consequently regulates energy expenditure and improves glucose and lipid homeostasis80,82.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [80]
In the citing paper
“while it signals the CNS to increase energy expenditure and decrease body weight [169,171,172] (Figure 2).”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [172]
In the citing paper
“The chronic metabolic effects of FGF21 on body weight and glucose homeostasis are lost when β-klotho is deleted from the CNS (Klbfl/fl;Camk2a-Cre) (101, 126).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
In the citing paper
“FGF21 administration increases sympathetic nerve activity to BAT (101) and WAT (28), and browning of WAT depots (28, 101).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
In the citing paper
“The administration of a corticotropin-releasing hormone antagonist blocks FGF21-mediated increases in sympathetic nerve activity to BAT (101).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
In the citing paper
“Interestingly, FGF21-mediated increases in sympathetic nerve activity to BAT appear to require hypothalamic corticotropin-releasing hormone.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brown Adipose Tissue: Function and Physiological Significance
CANNON, B., & NEDERGAARD, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00015.2003 · Cited by 6,433
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis
Fisher, F. M., Kleiner, S., Douris, N., Fox, E. C., Mepani, R. J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J. S., Maratos-Flier, E., et al. (2012) · Genes & Development · doi:10.1101/gad.177857.111 · Cited by 1,478 · cited 8×
“FGF21 also promotes the browning of scWAT (Fisher et al., 2012), an effect that in vivo involves bKlotho in the nervous system.”
InfluentialXu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.005 · Cited by 885
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y.-F., Clutinger, C. K., Tigno, X. T., Hansen, B. C., Shanafelt, A. B., & Etgen, G. J. (2007) · Endocrinology · doi:10.1210/en.2006-1168 · Cited by 738
Fon Tacer, K., Bookout, A. L., Ding, X., Kurosu, H., John, G. B., Wang, L., Goetz, R., Mohammadi, M., Kuro-o, M., Mangelsdorf, D. J., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0142 · Cited by 700
Self-citationLin, Z., Tian, H., Lam, K. S. L., Lin, S., Hoo, R. C. L., Konishi, M., Itoh, N., Wang, Y., Bornstein, S. R., Xu, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.005 · Cited by 691
BMP8B Increases Brown Adipose Tissue Thermogenesis through Both Central and Peripheral Actions
Whittle, A. J., Carobbio, S., Martins, L., Slawik, M., Hondares, E., Vázquez, M. J., Morgan, D., Csikasz, R. I., Gallego, R., Rodriguez-Cuenca, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.066 · Cited by 573
Self-citation
Cited by
Sorted by citations
Items 201–300 of 519
Fibroblast growth factor 21 has no direct role in regulating fertility in female mice
Singhal, G., Douris, N., Fish, A. J., Zhang, X., Adams, A. C., Flier, J. S., Pissios, P., & Maratos-Flier, E. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.010 · Cited by 38
Lee, D. V., Li, D., Yan, Q., Zhu, Y., Goodwin, B. J., Calle, R. A., Brenner, M. B., & Talukdar, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111767 · Cited by 38
A BAT-Centric Approach to the Treatment of Diabetes: Turn on the Brain
Hankir, M. K., Cowley, M. A., & Fenske, W. K. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.003 · Cited by 39
Yan, Z., Kronemberger, A., Blomme, J., Call, J. A., Caster, H. M., Pereira, R. O., Zhao, H., Melo, V. U. D., Laker, R. C., Zhang, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08480-2 · Cited by 38
Neuronal modulation of brown adipose activity through perturbation of white adipocyte lipogenesis
Guilherme, A., Pedersen, D. J., Henriques, F. D. S., Bedard, A. H., Henchey, E., Kelly, M., Morgan, D. A., Rahmouni, K., & Czech, M. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.014 · Cited by 40
Self-citationLi, S., Zou, T., Chen, J., Li, J., & You, J. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.06.033 · Cited by 37
Izaguirre, M., Gil, M. J., Monreal, I., Montecucco, F., Frühbeck, G., & Catalán, V. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0866-3 · Cited by 41
Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
Duszka, K., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082210 · Cited by 37
Ritchie, M. M., Hanouneh, I. A., Noureddin, M., Rolph, T., & Alkhouri, N. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1718104 · Cited by 37
Claflin, K. E., Sullivan, A. I., Naber, M. C., Flippo, K. H., Morgan, D. A., Neff, T. J., Jensen-Cody, S. O., Zhu, Z., Zingman, L. V., Rahmouni, K., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101564 · Cited by 37
Self-citationHua, L., Zhuo, Y., Jiang, D., Li, J., Huang, X., Yingguo, Z., Li, Z., Yan, L., Jin, C., Jiang, X., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800240r · Cited by 37
Emerging Structure–Function Paradigm of Endocrine FGFs in Metabolic Diseases
Luo, Y., Ye, S., Li, X., & Lu, W. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.12.002 · Cited by 37
Cooke, D., Mattocks, D. A. L., Nichenametla, S. N., Anunciado‐Koza, R. P., Koza, R. A., & Ables, G. P. (2020) · Obesity · doi:10.1002/oby.22763 · Cited by 36
Ohta, H., Konishi, M., Kobayashi, Y., Kashio, A., Mochiyama, T., Matsumura, S., Inoue, K., Fushiki, T., Nakao, K., Kimura, I., et al. (2015) · Scientific Reports · doi:10.1038/srep10049 · Cited by 37
Leptin Reduction as a Required Component for Weight Loss
Zhao, S., Li, N., Xiong, W., Li, G., He, S., Zhang, Z., Zhu, Q., Jiang, N., Ikejiofor, C., Zhu, Y., et al. (2023) · Diabetes · doi:10.2337/db23-0571 · Cited by 35
FGF21, energy expenditure and weight loss – How much brown fat do you need?
Straub, L. G., & Wolfrum, C. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.06.008 · Cited by 35
Le, C. T., Nguyen, G., Park, S. Y., Choi, D. H., & Cho, E.-H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192146 · Cited by 35
The anti-obesity effect of FGF19 does not require UCP1-dependent thermogenesis
Antonellis, P. J., Droz, B. A., Cosgrove, R., O’Farrell, L. S., Coşkun, T., Perfield, J. W., Bauer, S. M., Wade, M. R., Chouinard, T. E., Brozinick, J. T., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.006 · Cited by 37
Queen, N. J., Bates, R., Huang, W., Xiao, R., Appana, B., & Cao, L. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.12.011 · Cited by 38
Protein Appetite at the Interface between Nutrient Sensing and Physiological Homeostasis
Khan, M. S. H., Spann, R. A., Münzberg, H., Yu, S., Albaugh, V. L., He, Y., Berthoud, H., & Morrison, C. D. (2021) · Nutrients · doi:10.3390/nu13114103 · Cited by 35
Therapeutic Approaches to Alzheimer’s Type of Dementia: A Focus on FGF21 Mediated Neuroprotection
Taliyan, R., Chandran, S. K., & Kakoty, V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716101411 · Cited by 35
Glucagon receptor signaling regulates weight loss via central KLB receptor complexes
Nason, S. R., Antipenko, J., Presedo, N., Cunningham, S. E., Pierre, T. H., Kim, T., Paul, J. R., Holleman, C., Young, M. E., Gamble, K. L., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.141323 · Cited by 34
Miao, X., Alidadipour, A., Saed, V., Sayyadi, F., Jadidi, Y., Davoudi, M., Amraee, F., Jadidi, N., & Afrisham, R. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02335-9 · Cited by 37
Adipose Tissue and Energy Expenditure: Central and Peripheral Neural Activation Pathways
Blaszkiewicz, M., & Townsend, K. L. (2016) · Current Obesity Reports · doi:10.1007/s13679-016-0216-9 · Cited by 34
Dietary protein dilution limits dyslipidemia in obesity through FGF21-driven fatty acid clearance
Maida, A., Zota, A., Vegiopoulos, A., Appak‐Baskoy, S., Augustin, H. G., Heikenwälder, M. F., Herzig, S., & Rose, A. J. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.027 · Cited by 34
Beige Fat, Adaptive Thermogenesis, and Its Regulation by Exercise and Thyroid Hormone
Phillips, K. J. (2019) · Biology · doi:10.3390/biology8030057 · Cited by 35
Regulation of thermogenic adipocytes during fasting and cold
Reinisch, I., Schreiber, R., & Prokesch, A. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110869 · Cited by 36
Castañé, H., Baiges‐Gayà, G., Hernández‐Aguilera, A., Rodríguez‐Tomàs, E., Fernández‐Arroyo, S., Herrero, P., Delpino-Rius, A., Canela-Canela, N., Menéndez, J. A., Camps, J., et al. (2021) · Biomolecules · doi:10.3390/biom11030473 · Cited by 34
Modulation of energy balance by fibroblast growth factor 21
Ramos, D. C., & Aguilar-Salinas, C. A. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0023 · Cited by 36
Mechanistic insights into the liver–brain axis during chronic liver disease
Siddle, M. R., Durán, R. G., Goel, D., Renquist, B. J., Holt, M. K., & Hadjihambi, A. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01142-z · Cited by 36
FGF21 increases water intake, urine output and blood pressure in rats
Turner, T., Chen, X., Zahner, M. R., Opsahl, A., DeMarco, G. J., Boucher, M., Goodwin, B. J., & Perreault, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202182 · Cited by 33
Lin, J., Jiang, X., Dong, M., Liu, X., Shen, Q., Huang, Y., Zhang, H., Ye, R., Zhou, H., Yan, C., et al. (2021) · Advanced Science · doi:10.1002/advs.202101991 · Cited by 33
En, M., Kazantseva, A. Y., Dubinina, A., Jakovleva, T., Balybina, N., Baranov, K. O., & Бажан, Н. М. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910561 · Cited by 33
Thermogenic adipose tissue aging: Mechanisms and implications
Silva, G. D. N., & Amato, A. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.955612 · Cited by 39
Katsu-Jiménez, Y., & Giménez-Cassina, A. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103415 · Cited by 34
Bresciani, N., Demagny, H., Lemos, V., Pontanari, F., Li, X., Sun, Y., Li, H., Perino, A., Auwerx, J. H., & Schoonjans, K. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.040 · Cited by 34
Stone, K. P., Wanders, D., Calderon, L. F., Spurgin, S. B., Scherer, P. E., & Gettys, T. W. (2015) · Obesity · doi:10.1002/oby.21177 · Cited by 32
Exercise-regulated lipolysis: Its role and mechanism in health and diseases
Zhu, J., & Guo, L. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.11.031 · Cited by 33
Zhang, Y., Cao, X., Chen, L., Qin, Y., Xu, Y., Tian, Y., & Chen, L. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12848 · Cited by 31
Mice lacking triglyceride synthesis enzymes in adipose tissue are resistant to diet-induced obesity
Chitraju, C., Fischer, A. W., Ambaw, Y. A., Wang, K., Yuan, B., Hui, S. T., Walther, T. C., & Farese, R. V. (2023) · eLife · doi:10.7554/elife.88049 · Cited by 36
García-Gaytán, A. C., Miranda‐Anaya, M., Turrubiate, I., Portugal, L. L.-D., Bocanegra-Botello, G. N., López-Islas, A., Díaz‐Muñoz, M., & Méndez, I. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-66538-0 · Cited by 30
Hua, L., Li, J., Feng, B., Jiang, D., Jiang, X., Luo, T., Che, L., Xu, S., Lin, Y., Fang, Z., et al. (2020) · Endocrinology · doi:10.1210/endocr/bqaa244 · Cited by 30
Yılmaz, Ü., Tekin, S., Demir, M. T., Çiğremiş, Y., & Sandal, S. (2018) · The Journal of Physiological Sciences · doi:10.1007/s12576-018-0595-7 · Cited by 30
Rinella, M. E., & Sookoian, S. C. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01187-8 · Cited by 31
Xiang, A. S., Meikle, P. J., Carey, A. L., & Kingwell, B. A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.07.002 · Cited by 29
Forney, L. A., Stone, K. P., Wanders, D., & Gettys, T. W. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.12.002 · Cited by 28
Xiao, F., Guo, Y., Deng, J., Yuan, F., Xiao, Y., Hui, L., Li, Y., Hu, Z., Zhou, Y., Li, K., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.12.003 · Cited by 28
Moure, R., Cairó, M., Morón‐Ros, S., Quesada‐López, T., Campderrós, L., Cereijo, R., Hernáez, Á., Villarroya, F., & Giralt, M. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00270.2020 · Cited by 28
Rojas, J. M., Matsen, M. E., Mundinger, T. O., Morton, G. J., Stefanovski, D., Bergman, R. N., Kaiyala, K. J., Taborsky, G. J., & Schwartz, M. W. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.05.005 · Cited by 28
Adapting to the cold: A role for endogenous fibroblast growth factor 21 in thermoregulation?
Klein Hazebroek, M., & Keipert, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00389 · Cited by 27
Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease
Kakoty, V., Sarathlal, K. C., Tang, R.-D., Yang, C. H., Dubey, S. K., & Taliyan, R. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110145 · Cited by 27
Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease
Chikamatsu, M., Watanabe, H., Shintani, Y., Murata, R., Miyahisa, M., Nishinoiri, A., Imafuku, T., Takano, M., Arimura, N., Yamada, K., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.039 · Cited by 27
IDOL regulates systemic energy balance through control of neuronal VLDLR expression
Lee, S. D., Priest, C., Bjursell, M., Gao, J., Arneson, D. V., Ahn, I. S., Diamante, G., van Veen, J. E., Massa, M. G., Calkin, A. C., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0127-7 · Cited by 26
Contribution of adaptive thermogenesis to the hypothalamic regulation of energy balance
Lage, R., Fernø, J., Nogueiras, R., Diéguez, C., & López, M. (2016) · Biochemical Journal · doi:10.1042/bcj20160012 · Cited by 28
Central α-Klotho Suppresses NPY/AgRP Neuron Activity and Regulates Metabolism in Mice
Landry, T., Laing, B. T., Li, P.-X., Bunner, W., Rao, Z., Prete, A., Sylvestri, J., & Hu, H. (2020) · Diabetes · doi:10.2337/db19-0941 · Cited by 26
Brown adipocyte ATF4 activation improves thermoregulation and systemic metabolism
Paulo, E., Zhang, Y., Masand, R., Huynh, T. L., Seo, Y., Swaney, D. L., Soucheray, M., Stevenson, E. J., Jimenez‐Morales, D., Krogan, N. J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109742 · Cited by 26
Hepatic Phospholipid Remodeling Modulates Insulin Sensitivity and Systemic Metabolism
Tian, Y., Mehta, K., Jellinek, M. J., Sun, H., Lu, W., Shi, R., Ingram, K., Friedline, R. H., Kim, J. K., Kemper, J. K., et al. (2023) · Advanced Science · doi:10.1002/advs.202300416 · Cited by 26
Hepatocyte β‐Klotho regulates lipid homeostasis but not body weight in mice
Kobayashi, K., Tanaka, T., Okada, S., Morimoto, Y., Matsumura, S., Manio, M. C. C., Inoue, K., Kimura, K., Yagi, T., Saito, Y., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-274449 · Cited by 27
β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice
Somm, E., Henry, H., Bruce, S. J., Bonnet, N., Montandon, S. A., Niederländer, N. J., Messina, A., Aeby, S., Rosikiewicz, M., Fajas, L., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00182.2018 · Cited by 28
Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/db and DIO mice
Zhao, L., Wang, H., Xie, J.-J., Chen, Z., Li, X., & Niu, J. (2017) · BMC Biotechnology · doi:10.1186/s12896-017-0368-z · Cited by 25
Chang, J. C., Durinck, S., Chen, M. Z., Martinez-Martín, N., Zhang, J. A., Lehoux, I. E., Li, H., Lin, M. H., Wu, J., Bainbridge, T. W., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45354-1 · Cited by 24
Advances in Biological Functions and Clinical Studies of FGF21
Lin, W. J., Zhang, T., Zhou, Y., Zheng, J., & Lin, Z. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s317096 · Cited by 24
A pyrexic effect of FGF21 independent of energy expenditure and UCP1
Zouhar, P., Janovská, P., Stanić, S., Bardová, K., Funda, J., Haberlova, B., Andersen, B., Rossmeisl, M., Cannon, B., Kopecký, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101324 · Cited by 24
Hepatic p38 Activation Modulates Systemic Metabolism Through FGF21-Mediated Interorgan Communication
Liu, W., Sun, C., Yan, Y., Cao, H., Niu, Z., Shen, S., Liu, S., Wu, Y., Yan, L., Hui, L., et al. (2021) · Diabetes · doi:10.2337/db21-0240 · Cited by 24
Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
Shimizu, M., & Sato, R. (2022) · Cells · doi:10.3390/cells11030505 · Cited by 25
Larson, K. R., Jayakrishnan, D., Sauza, K. A. S., Goodson, M. L., CHAFFIN, A. T. B., Davidyan, A., Pathak, S. J., Fang, Y., Magaña, D. G., Miller, B. F., et al. (2024) · Endocrinology · doi:10.1210/endocr/bqae004 · Cited by 24
Pérez‐Martí, A., Sandoval, V., Marrero, P. F., Haro, D., & Relat, J. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0034 · Cited by 24
Chang, H. H., Chen, P. S., Cheng, Y. W., Wang, T., Yang, Y. K., & Lu, R. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx093 · Cited by 24
Nutritional Regulation of Hepatic FGF21 by Dietary Restriction of Methionine
Fang, H., Stone, K. P., Forney, L. A., Wanders, D., & Gettys, T. W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.773975 · Cited by 24
Local acetate inhibits brown adipose tissue function
Sun, W., Dong, H., & Wolfrum, C. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116125118 · Cited by 26
Thermogenic Fat: Development, Physiological Function, and Therapeutic Potential
Brandão, B. B., Poojari, A., & Rabiee, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115906 · Cited by 25
Monnard, C. R., & Grasser, E. K. (2018) · Advances in Nutrition · doi:10.1093/advances/nmx023 · Cited by 23
Hansen, A. M. K., Vienberg, S. G., Lykkegaard, K., Zhao, X., Tingqing, G., Han, D., Zhang, X., Thøgersen, H., Sass‐Ørum, K., Tagmose, T. M., et al. (2018) · Biochemical Journal · doi:10.1042/bcj20180555 · Cited by 23
Zhu, S., Ying, Y., Ye, L., Ying, W., Ye, J., Wu, Q., Chen, M., Zhu, H., Li, X., Dou, H., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.628369 · Cited by 23
Kim, Y. J., Kim, H. J., Lee, S. G., Kim, D. H., Jang, S., Go, H. S., Lee, W. J., & Seong, J. K. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155178 · Cited by 23
Hormonal factors in the control of the browning of white adipose tissue
Hu, J., & Christian, M. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0017 · Cited by 22
Admin, A., Hollstein, T., Heinitz, S., Ando, T., Rodzevik, T. L., Basolo, A., Walter, M., Chang, D. C., Krakoff, J., & Piaggi, P. (2020) · Diabetes · doi:10.2337/db20-0153 · Cited by 23
Li, L., Wang, H., Pang, S., Wang, L., Fan, Z., Ma, C., Yang, S., Banda, J., Hui, Q., Lv, F., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105127 · Cited by 22
Chu, Y., Gui, S., Zheng, Y., Zhao, J., Zhao, Y., Li, Y., & Chen, X. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176438 · Cited by 22
Hepatic-specific PPARα-FGF21 action in NAFLD
Piccinin, E., & Moschetta, A. (2016) · Gut · doi:10.1136/gutjnl-2016-311408 · Cited by 22
Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis
Russo, L., Ghadieh, H. E., Ghanem, S. S., Al–Share, Q. Y., Smiley, Z. N., Gatto-Weis, C. M., Esakov, E. L., McInerney, M. F., Heinrich, G., Tong, X., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m072066 · Cited by 22
Chang, H. C., Di, T., Wang, Y., Zeng, X., Li, G., Wan, Q., Yu, W., & Chen, L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.023 · Cited by 22
Fibroblast growth factor 21: A “rheostat” for metabolic regulation?
She, Q.-Y., Bao, J., Wang, H.-Z., Liang, H., Huang, W., Wu, J., Zhong, Y.-W., Ling, H., Li, A., & Qin, S.-L. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155166 · Cited by 22
Fibroblast Growth Factor 21 Facilitates the Homeostatic Control of Feeding Behavior
Wu, C.-T., CHAFFIN, A. T. B., & Ryan, K. K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030580 · Cited by 24
Chu, Y., Yang, S., & Chen, X. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108844 · Cited by 21
Takeuchi, K., Yamaguchi, K., Takahashi, Y., Yano, K., Okishio, S., Ishiba, H., Tochiki, N., Kataoka, S., Fujii, H., Iwai, N., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-75107-8 · Cited by 21
Gavrieli, A., & Mantzoros, C. S. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.3.361 · Cited by 21
Transcriptional coordination of hepatic autophagy by nutrient-sensing nuclear receptor PPARα and FXR
Lee, J. M. (2016) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2016.21.4.193 · Cited by 21
Ippagunta, S. M., Kharitonenkov, A., Adams, A. C., & Hillgartner, F. B. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy022 · Cited by 21
Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence
Hollstein, T., & Piaggi, P. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00371-4 · Cited by 24
Relationship between FGF21 and drug or nondrug therapy of type 2 diabetes mellitus
Guo, C. Y., Zhao, L., Li, Y., Deng, X., & Yuan, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29879 · Cited by 21
Fischer, A. W., Behrens, J. R., Sass, F., Schlein, C., Heine, M., Pertzborn, P., Scheja, L., & Heeren, J. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000455 · Cited by 21
Nielsen, M. H., Gillum, M. P., Vrang, N., Jelsing, J., Hansen, H. H., Feigh, M., & Oró, D. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00157.2022 · Cited by 20
Stanić, S., Bardová, K., Janovská, P., Rossmeisl, M., Kopecký, J., & Zouhar, P. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116042 · Cited by 20
Current understanding and controversies on the clinical implications of fibroblast growth factor 21
Badakhshi, Y., & Jin, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1864278 · Cited by 20
En, M., Kazantseva, A. Y., Dubinina, A., Denisova, E. I., Jakovleva, T., Balybina, N., Bgatova, N. P., Baranov, K. O., & Бажан, Н. М. (2021) · Cells · doi:10.3390/cells10123440 · Cited by 20
Giralt, M., Cairó, M., & Villarroya, F. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.08.005 · Cited by 19
FGF21 decreases food intake and body weight in obese Göttingen minipigs
Christoffersen, B. Ø., Straarup, E. M., Lykkegaard, K., Fels, J. J., Sass‐Ørum, K., Zhang, X., Raun, K., & Andersen, B. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13560 · Cited by 19
Bono, B. S. M., Ly, N. K. K., Miller, P. A., Williams-Ikhenoba, J. G., Dumiaty, Y., & Chee, M. J. S. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25306 · Cited by 19
Lester, S. G., Russo, L., Ghanem, S. S., Khuder, S. S., DeAngelis, A. M., Esakov, E. L., Bowman, T. A., Heinrich, G., Al–Share, Q. Y., McInerney, M. F., et al. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00116 · Cited by 19
Metadata
- Authors
- Owen, B. M., Ding, X., Morgan, D. A., Coate, K. C., Bookout, A. L., Rahmouni, K., Kliewer, S. A., & Mangelsdorf, D. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Kliewer, Steven A.
- Mangelsdorf, David J.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 20
- Issue
- 4
- Pages
- 670-677
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC4192037
- OpenAlex
- W2158477352
- Cited by
- 523
- References
- 45
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 40 · 2023: 43 · 2022: 49 · 2021: 38 · 2020: 49 · 2019: 46 · 2018: 50 · 2017: 44 · 2016: 39 · 2015: 47 · 2014: 3
- FWCI
- 18.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1F32DK098908, GM007062, HL084207, R01DK067158)
- Howard Hughes Medical Institute
- Welch Foundation (I-1275, I-1558)
- American Heart Association (14EIA18860041)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- FGF21, β-Klotho, central nervous system, sympathetic activity, brown adipose tissue, energy expenditure, weight loss, corticotropin-releasing factor, obesity, tissue-specific knockout mice
- MeSH terms
- Klotho Proteins, Animals, Adipose Tissue, Brown, Corticotropin-Releasing Hormone, Energy Metabolism, Fibroblast Growth Factors, Hypothalamus, Membrane Proteins, Mice, Inbred C57BL, Mice, Obese, Mice, Transgenic, RNA, Messenger, Sympathetic Nervous System, Weight Loss, Mice, Knockout, Thermogenesis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
